WHO recommends two new lifesaving medicines to treat Ebola — Global Issues
The recommendation follows review and analysis of clinical trials for the monoclonal antibodies mAb114 (known as Ansuvimab or Ebanga) and REGN-EB3 (Inmazeb), which have demonstrated clear benefits for people who have tested positive for Ebola, which is often fatal. This includes older persons, pregnant and breastfeeding women, children, and newborns…